Participant flow14

How many started, completed or left each group, period by period.

1 to 14 of 14

Period	Milestone	Group	Participants
Overall Study	STARTED	Entecavir (ETV) 1.0 mg	100
Overall Study	STARTED	Adefovir (ADV) 10 mg	91
Overall Study	Treated (As-Randomized Population)	Entecavir (ETV) 1.0 mg	100
Overall Study	Treated (As-Randomized Population)	Adefovir (ADV) 10 mg	91
Overall Study	Treated (As-Treated Population)	Entecavir (ETV) 1.0 mg	102
Overall Study	Treated (As-Treated Population)	Adefovir (ADV) 10 mg	89
Overall Study	Treated, Wk 48 (As-Treated Population)	Entecavir (ETV) 1.0 mg	102
Overall Study	Treated, Wk 48 (As-Treated Population)	Adefovir (ADV) 10 mg	89
Overall Study	Treated, 24-Week Follow-Up Population	Entecavir (ETV) 1.0 mg	25
Overall Study	Treated, 24-Week Follow-Up Population	Adefovir (ADV) 10 mg	28
Overall Study	COMPLETED	Entecavir (ETV) 1.0 mg	71
Overall Study	COMPLETED	Adefovir (ADV) 10 mg	62
Overall Study	NOT COMPLETED	Entecavir (ETV) 1.0 mg	29
Overall Study	NOT COMPLETED	Adefovir (ADV) 10 mg	29

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00065507/flow